Axsome Therapeutics Files 8-K
Ticker: AXSM · Form: 8-K · Filed: May 27, 2025 · CIK: 1579428
| Field | Detail |
|---|---|
| Company | Axsome Therapeutics, INC. (AXSM) |
| Form Type | 8-K |
| Filed Date | May 27, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: filing, sec, financials
Related Tickers: AXSM
TL;DR
AXSM filed an 8-K, likely containing important updates. Check for details.
AI Summary
Axsome Therapeutics, Inc. filed an 8-K on May 27, 2025, reporting other events and financial statements. The filing does not contain specific details on new events or financial figures but serves as a notification of these items.
Why It Matters
This filing indicates that Axsome Therapeutics is providing updates or submitting required financial documentation to the SEC, which could contain material information for investors.
Risk Assessment
Risk Level: low — The filing is a standard procedural document without immediate negative or positive financial implications disclosed.
Key Players & Entities
- Axsome Therapeutics, Inc. (company) — Registrant
- May 27, 2025 (date) — Date of earliest event reported
- 001-37635 (other) — Commission File Number
- 454241907 (other) — IRS Employer Identification No.
FAQ
What specific 'Other Events' are being reported by Axsome Therapeutics in this 8-K filing?
The provided text of the 8-K filing does not specify the details of the 'Other Events' being reported, only that this item is being addressed.
What is the significance of filing 'Financial Statements and Exhibits' on an 8-K?
Filing financial statements and exhibits on an 8-K typically means the company is disclosing material financial information or submitting required documentation as per SEC regulations.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on May 27, 2025.
What is Axsome Therapeutics' Commission File Number?
Axsome Therapeutics' Commission File Number is 001-37635.
Where is Axsome Therapeutics' principal executive office located?
Axsome Therapeutics' principal executive office is located at One World Trade Center, 29th Floor, New York, New York, 10007.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 27, 2025 regarding Axsome Therapeutics, Inc. (AXSM).